Error: Search field were incomplete.
This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.
Robert L. Findling, MD
Published: December 4, 2009
This CME activity is expired. For more CME activities, visit CMEInstitute.com.
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders
Bipolar disorder is an increasingly common diagnosis given to children and adolescents. Most studies of lithium, anticonvulsants, and atypical antipsychotics have been conducted in adult populations, but new data are providing information on the safety and tolerability of these medications for treating children and adolescents. Although generally well tolerated, psychotropic agents have different side effect profiles that should be considered when planning treatment regimens for pediatric patients. Additional controlled and comparative trials are needed on the safety and tolerability of these medications in young patients, especially for long-term maintenance treatment.
Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.
Child and Adolescent , Populations